The VIVA‐MIND study: Topline Results from Phase 2 RCT of Varoglutamstat in Early AD
Year: 2025
Type: article
Language: en
Topic: Neuroscience and Neuropharmacology Research
Authors and affiliations:
raw_author_name: Howard H. Feldman
raw_affiliation_strings: Alzheimer's Disease Cooperative Study, University of California San Diego, La Jolla, CA USA
Department of Neurosciences, University of California San Diego, La Jolla, CA USA
Shiley‐Marcos Alzheimer’s Disease Research Center, La Jolla, CA USA
raw_author_name: Karen Messer
raw_affiliation_strings: Alzheimer's Disease Cooperative Study, University of California San Diego, La Jolla, CA USA
Department of Neurosciences, University of California San Diego, La Jolla, CA USA
raw_author_name: Jing Zhang
raw_affiliation_strings: Alzheimer’s Disease Cooperative Study, University of California San Diego, La Jolla, CA USA
Department of Neurosciences, University of California San Diego, La Jolla, CA USA
raw_author_name: Natalie E Quach
raw_affiliation_strings: Alzheimer's Disease Cooperative Study, University of California San Diego, La Jolla, CA USA
Department of Neurosciences, University of California San Diego, La Jolla, CA USA
raw_author_name: Gabriel C Leger
raw_affiliation_strings: Alzheimer's Disease Cooperative Study, University of California San Diego, La Jolla, CA USA
Department of Neurosciences, University of California San Diego, La Jolla, CA USA
Shiley‐Marcos Alzheimer’s Disease Research Center, La Jolla, CA USA
raw_author_name: Diane M. Jacobs
raw_affiliation_strings: Alzheimer’s Disease Cooperative Study, University of California San Diego, La Jolla, CA USA
Department of Neurosciences, University of California San Diego, La Jolla, CA USA
UCSD Shiley‐Marcos Alzheimer's Disease Research Center, La Jolla, CA USA
raw_author_name: Steven D Edland
raw_affiliation_strings: Alzheimer's Disease Cooperative Study, University of California San Diego, La Jolla, CA USA
Department of Neurosciences, University of California San Diego, San Diego, CA USA
Shiley‐Marcos Alzheimer’s Disease Research Center, La Jolla, CA USA
raw_author_name: Jasmin Duehring
raw_affiliation_strings: Alzheimer's Disease Cooperative Study, University of California San Diego, La Jolla, CA USA
Department of Neurosciences, University of California San Diego, La Jolla, CA USA
raw_author_name: Andrew MacKelfresh
raw_affiliation_strings: Alzheimer's Disease Cooperative Study, University of California San Diego, La Jolla, CA USA
Department of Neurosciences, University of California San Diego, La Jolla, CA USA
raw_author_name: Alessandra Pol
raw_affiliation_strings: Alzheimer's Disease Cooperative Study, University of California San Diego, La Jolla, CA USA
Department of Neurosciences, University of California San Diego, La Jolla, CA USA
raw_author_name: Carolyn Revta
raw_affiliation_strings: Alzheimer's Disease Cooperative Study, University of California San Diego, La Jolla, CA USA
Department of Neurosciences, University of California San Diego, La Jolla, CA USA
raw_author_name: Jody‐Lynn Lupo
raw_affiliation_strings: Alzheimer's Disease Cooperative Study, University of California San Diego, La Jolla, CA USA
Department of Neurosciences, University of California San Diego, La Jolla, CA USA
raw_author_name: Archana Balasubramanian
raw_affiliation_strings: Alzheimer's Disease Cooperative Study, University of California San Diego, La Jolla, CA USA
Department of Neurosciences, University of California San Diego, La Jolla, CA USA
raw_author_name: Nicola Lama
raw_affiliation_strings: Certara, Basel Switzerland
raw_author_name: Tanja Wassmann
raw_affiliation_strings: Vivoryon Therapeutics NV, Halle Germany
raw_author_name: Michael Schaeffer
raw_affiliation_strings: Vivoryon Therapeutics NV, Halle Germany
raw_author_name: Antje Meyer
raw_affiliation_strings: Vivoryon Therapeutics NV, Halle Germany
raw_author_name: Sylvia Schell‐Mader
raw_affiliation_strings: Vivoryon Therapeutics NV, Halle Germany
raw_author_name: Christine Wenzkowski
raw_affiliation_strings: Vivoryon Therapeutics NV, Halle Germany
raw_author_name: Frank Weber
raw_affiliation_strings: Vivoryon Therapeutics NV, Halle Germany
raw_author_name: ADCS VIVA‐MIND Study Group